-
1
-
-
0026664249
-
Intranasal insulin: Clinical pharmacokinetics
-
[1] L. Illum and S.S. Davis, Intranasal insulin: clinical pharmacokinetics, Clin. Pharmacokinet. 23 (1992) 30-41.
-
(1992)
Clin. Pharmacokinet.
, vol.23
, pp. 30-41
-
-
Illum, L.1
Davis, S.S.2
-
3
-
-
0001089350
-
Nasal absorption of insulin: Enhancement by hydrophobic bile salts
-
[3] G.S. Gordon, A.C. Moses, R.D. Silver, J.S. Flier and M.C. Carey, Nasal absorption of insulin: enhancement by hydrophobic bile salts, Proc. Natl. Acad. Sci. USA 82 (1985) 7419-7423.
-
(1985)
Proc. Natl. Acad. Sci. USA
, vol.82
, pp. 7419-7423
-
-
Gordon, G.S.1
Moses, A.C.2
Silver, R.D.3
Flier, J.S.4
Carey, M.C.5
-
4
-
-
0020051102
-
Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects
-
[4] A.E. Pontiroli, M. Alberetto, A. Secchi, G. Dossi, I. Bosi and G. Pozza, Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects, Br. Med. J. 284 (1982) 303-306.
-
(1982)
Br. Med. J.
, vol.284
, pp. 303-306
-
-
Pontiroli, A.E.1
Alberetto, M.2
Secchi, A.3
Dossi, G.4
Bosi, I.5
Pozza, G.6
-
5
-
-
0023640678
-
Human insulin plus sodium glycocholate in a nasal spray formulation: Improved bioavailability and effectiveness in normal subjects
-
[5] A.E. Pontiroli, M. Alberetto, E. Pajetta, A. Calderara and G. Pozza, Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects, Diab. Metab. 13 (1987) 441-443.
-
(1987)
Diab. Metab.
, vol.13
, pp. 441-443
-
-
Pontiroli, A.E.1
Alberetto, M.2
Pajetta, E.3
Calderara, A.4
Pozza, G.5
-
6
-
-
0021034494
-
Insulin administered intranasally as an insulin-bile salt aerosol: Effectiveness and reproducibility in normal and diabetic subjects
-
[6] A.C. Moses, G.S. Gordon, M.C. Carey and J.S. Flier, Insulin administered intranasally as an insulin-bile salt aerosol: effectiveness and reproducibility in normal and diabetic subjects, Diabetes 32 (1983) 1040-1047.
-
(1983)
Diabetes
, vol.32
, pp. 1040-1047
-
-
Moses, A.C.1
Gordon, G.S.2
Carey, M.C.3
Flier, J.S.4
-
7
-
-
0023618986
-
Long-term use of intranasal insulin in insulin-dependent diabetic patients
-
[7] A.G. Frauman, M.E. Cooper, B.J. Parsons, G. Jerums and W.J. Louis, Long-term use of intranasal insulin in insulin-dependent diabetic patients, Diabetes Care 10 (1987) 573-578.
-
(1987)
Diabetes Care
, vol.10
, pp. 573-578
-
-
Frauman, A.G.1
Cooper, M.E.2
Parsons, B.J.3
Jerums, G.4
Louis, W.J.5
-
8
-
-
0025248878
-
Insulin administration in insulin dependent diabetes: Reproducibility of its absorption and effects
-
[8] I.R. Sinay, S. Sclimovich, S. Damilano, A.L. Cagide, M.C. Faingold, E.B. Facco, M.S. Gurfinkel and P. Arias, Insulin administration in insulin dependent diabetes: reproducibility of its absorption and effects, Horm. Metab. Res. 22 (1990) 307-308.
-
(1990)
Horm. Metab. Res.
, vol.22
, pp. 307-308
-
-
Sinay, I.R.1
Sclimovich, S.2
Damilano, S.3
Cagide, A.L.4
Faingold, M.C.5
Facco, E.B.6
Gurfinkel, M.S.7
Arias, P.8
-
9
-
-
0023616681
-
Preprandial intranasal insulin as adjuvant therapy in type 2 diabetics
-
[9] M. El-Etr, G. Slama and N. Desplanque, Preprandial intranasal insulin as adjuvant therapy in type 2 diabetics. Lancet II (1987) 1085-1086.
-
(1987)
Lancet
, vol.2
, pp. 1085-1086
-
-
El-Etr, M.1
Slama, G.2
Desplanque, N.3
-
10
-
-
0025894020
-
Meal-time intranasal insulin delivery in type II diabetes
-
[10] D.G. Bruce, D.J. Chisholm, L.H. Stoelien, M. Borkman and E.W. Kraegen, Meal-time intranasal insulin delivery in type II diabetes, Diabetic Med. 8 (1991) 366-370.
-
(1991)
Diabetic Med.
, vol.8
, pp. 366-370
-
-
Bruce, D.G.1
Chisholm, D.J.2
Stoelien, L.H.3
Borkman, M.4
Kraegen, E.W.5
-
11
-
-
0023244003
-
Effects of intranasal insulin in nonobese type II diabetes
-
[11] A.G. Frauman, G. Jerums and W.J. Louis, Effects of intranasal insulin in nonobese type II diabetes, Diabetes Res. Clin. Pract. 3 (1987) 197-202.
-
(1987)
Diabetes Res. Clin. Pract.
, vol.3
, pp. 197-202
-
-
Frauman, A.G.1
Jerums, G.2
Louis, W.J.3
-
12
-
-
84910861471
-
Intranasal insulin (INI) treatment of type I diabetes: Clinical and immunological effects using two different absorption enhancing adjuvants
-
[12] A.G. Frauman, R. Buchanan, G. Jerums and W.J. Louis, Intranasal insulin (INI) treatment of type I diabetes: clinical and immunological effects using two different absorption enhancing adjuvants, Diabetes Res. Clin. Pract. 5 (Suppl. 1) (1988) 5162.
-
(1988)
Diabetes Res. Clin. Pract.
, vol.5
, Issue.SUPPL. 1
, pp. 5162
-
-
Frauman, A.G.1
Buchanan, R.2
Jerums, G.3
Louis, W.J.4
-
13
-
-
0021918027
-
Intranasal aerosolized insulin
-
[13] R. Salzman, J.E. Manson, G.T. Griffing, R. Kimmerle, N. Ruderman, A. McCall, E.J. Stoltz, C. Mullin, S. Small, J. Armstrong and J.C. Melby, Intranasal aerosolized insulin, N. Engl. J. Med. 312 (1985) 1078-1084.
-
(1985)
N. Engl. J. Med.
, vol.312
, pp. 1078-1084
-
-
Salzman, R.1
Manson, J.E.2
Griffing, G.T.3
Kimmerle, R.4
Ruderman, N.5
McCall, A.6
Stoltz, E.J.7
Mullin, C.8
Small, S.9
Armstrong, J.10
Melby, J.C.11
-
14
-
-
0012021490
-
Nasal absorption of insulin
-
[14] A.C. Moses, Nasal absorption of insulin, Pharm. Weekbl. Sci. Ed. 10 (1988) 45-46.
-
(1988)
Pharm. Weekbl. Sci. Ed.
, vol.10
, pp. 45-46
-
-
Moses, A.C.1
-
15
-
-
0025307844
-
Biological activity of nasally administered insulin in normal subjects
-
[15] M.S. Nolte, C. Taboga, E. Salamon, A. Moses, J. Longenecker, J. Flier and J.H. Karam, Biological activity of nasally administered insulin in normal subjects, Horm. Metab. Res. 22 (1990) 170-174.
-
(1990)
Horm. Metab. Res.
, vol.22
, pp. 170-174
-
-
Nolte, M.S.1
Taboga, C.2
Salamon, E.3
Moses, A.4
Longenecker, J.5
Flier, J.6
Karam, J.H.7
-
17
-
-
0026578922
-
Intranasal administration of insulin with phospholipids as absorption enhancer: Pharmacokinetics in normal subjects
-
[17] K. Drejer, A. Vaag, K. Bech, P. Hansen, A.R. Sørensen and N. Mygind, Intranasal administration of insulin with phospholipids as absorption enhancer: pharmacokinetics in normal subjects, Diabetic Med. 9 (1992) 335-340.
-
(1992)
Diabetic Med.
, vol.9
, pp. 335-340
-
-
Drejer, K.1
Vaag, A.2
Bech, K.3
Hansen, P.4
Sørensen, A.R.5
Mygind, N.6
-
18
-
-
0027375767
-
The pharmacodynamics and activity of intranasally administered insulin in healthy male volunteers
-
[18] M.A.J.M. Jacobs, R.H. Schreuder, K. Jap-A-Joe, J.J. Nauta, P.M. Andersen and R.J. Heine, The pharmacodynamics and activity of intranasally administered insulin in healthy male volunteers, Diabetes 42 (1993) 1649-1655.
-
(1993)
Diabetes
, vol.42
, pp. 1649-1655
-
-
Jacobs, M.A.J.M.1
Schreuder, R.H.2
Jap-A-Joe, K.3
Nauta, J.J.4
Andersen, P.M.5
Heine, R.J.6
-
19
-
-
0029061032
-
Intranasal insulin therapy: The clinical realities
-
[19] J. Hilsted, S. Madsbad, A. Hvidberg, M.H. Rasmussen, T. Krarup, H. Ipsen, B. Hansen, M. Pedersen, R. Djurup and B. Oxenbøll, Intranasal insulin therapy: the clinical realities, Diabetologia 38 (1995) 680-684.
-
(1995)
Diabetologia
, vol.38
, pp. 680-684
-
-
Hilsted, J.1
Madsbad, S.2
Hvidberg, A.3
Rasmussen, M.H.4
Krarup, T.5
Ipsen, H.6
Hansen, B.7
Pedersen, M.8
Djurup, R.9
Oxenbøll, B.10
-
20
-
-
85030207678
-
-
European Patent Application 883302118.1, November 16, 1983
-
[20] S. Hirai, H. Okada, T. Yashjid and Y. Uda, Pharmaceutical composition and its use, European Patent Application 883302118.1, November 16, 1983.
-
Pharmaceutical Composition and its Use
-
-
Hirai, S.1
Okada, H.2
Yashjid, T.3
Y, U.4
-
21
-
-
0025878065
-
Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats
-
[21] F.W.H.M. Merkus, J.C. Verhoef, S.G. Romeijn and N.G.M. Schipper, Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats, Pharm. Res. 8 (1991) 588-592.
-
(1991)
Pharm. Res.
, vol.8
, pp. 588-592
-
-
Merkus, F.W.H.M.1
Verhoef, J.C.2
Romeijn, S.G.3
Schipper, N.G.M.4
-
22
-
-
0027241901
-
Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: Powder more effective than liquid formulations
-
[22] N.G.M. Schipper, S.G. Romeijn, J.C. Verhoef and F.W.H.M. Merkus, Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations, Pharm. Res. 10 (1993) 682-686.
-
(1993)
Pharm. Res.
, vol.10
, pp. 682-686
-
-
Schipper, N.G.M.1
Romeijn, S.G.2
Verhoef, J.C.3
Merkus, F.W.H.M.4
-
23
-
-
0012020497
-
Intranasal insulin absorption in volunteers and diabetes mellitus patients
-
Abstract No. 401
-
[23] F.W.H.M. Merkus, N.G.M. Schipper, J. Verhoef, R. Bianchi, E. Helmich-Teuben and D.W. Erkelens, Intranasal insulin absorption in volunteers and diabetes mellitus patients, Thérapie 50 (1995) Suppl. 1, Abstract No. 401.
-
(1995)
Thérapie
, vol.50
, Issue.SUPPL.
, pp. 1
-
-
Merkus, F.W.H.M.1
Schipper, N.G.M.2
Verhoef, J.3
Bianchi, R.4
Helmich-Teuben, E.5
Erkelens, D.W.6
-
24
-
-
0001062110
-
Faster, shorter and more profound action of Lys(B28) Pro(B29) human insulin analogue compared to regular insulin irrespective of the injection site
-
[24] E.W.T.M. ter Braak, R. Bianchi and D.W. Erkelens, Faster, shorter and more profound action of Lys(B28) Pro(B29) human insulin analogue compared to regular insulin irrespective of the injection site, Diabetes 42 (1993) 207A.
-
(1993)
Diabetes
, vol.42
-
-
Ter Braak, E.W.T.M.1
Bianchi, R.2
Erkelens, D.W.3
-
25
-
-
0001804127
-
Approaches to insulin analogues
-
[25] J.A. Galloway and R.E. Chance, Approaches to insulin analogues, Diabetes Annu. 8 (1994) 277-297.
-
(1994)
Diabetes Annu.
, vol.8
, pp. 277-297
-
-
Galloway, J.A.1
Chance, R.E.2
-
26
-
-
0026731720
-
Cyclodextrins as nasal absorption promoters of insulin: Mechanistic evaluations
-
[26] Z. Shao, R. Krishnamoorthy and A.K. Mitra, Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations, Pharm. Res. 9 (1992) 1157-1163.
-
(1992)
Pharm. Res.
, vol.9
, pp. 1157-1163
-
-
Shao, Z.1
Krishnamoorthy, R.2
Mitra, A.K.3
-
27
-
-
0027225230
-
Absorption enhancers in nasal drug delivery: Efficacy and safety
-
[27] F.W.H.M. Merkus, N.G.M. Schipper, W.A.J.J. Hermans, S.G. Romeijn and J.C. Verhoef, Absorption enhancers in nasal drug delivery: efficacy and safety, J. Control. Rel. 24 (1993) 201-208.
-
(1993)
J. Control. Rel.
, vol.24
, pp. 201-208
-
-
Merkus, F.W.H.M.1
Schipper, N.G.M.2
Hermans, W.A.J.J.3
Romeijn, S.G.4
Verhoef, J.C.5
-
28
-
-
0029149771
-
Effects of absorption enhancers on rat nasal epithelium in vivo: Release of marker compounds in the nasal cavity
-
[28] E. Marttin, J.C. Verhoef, S.G. Romeijn and F.W.H.M. Merkus, Effects of absorption enhancers on rat nasal epithelium in vivo: release of marker compounds in the nasal cavity, Pharm. Res. 12 (1995) 1151-1157.
-
(1995)
Pharm. Res.
, vol.12
, pp. 1151-1157
-
-
Marttin, E.1
Verhoef, J.C.2
Romeijn, S.G.3
Merkus, F.W.H.M.4
-
29
-
-
0028964619
-
Intranasal delivery of human growth hormone: Optimization of formulation
-
[29] K. Albertsson-Wikland, L. Hedin, P. Jansson, S. Rosberg and C. Wikström, Intranasal delivery of human growth hormone: optimization of formulation, Drug Dev. Res. 34 (1995) 353-360.
-
(1995)
Drug Dev. Res.
, vol.34
, pp. 353-360
-
-
Albertsson-Wikland, K.1
Hedin, L.2
Jansson, P.3
Rosberg, S.4
Wikström, C.5
-
30
-
-
0026518527
-
Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects
-
[30] T. Kissel, J. Drewe, S. Bantle, A. Rummelt and C. Beglinger, Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects, Pharm. Res. 9 (1992) 52-57.
-
(1992)
Pharm. Res.
, vol.9
, pp. 52-57
-
-
Kissel, T.1
Drewe, J.2
Bantle, S.3
Rummelt, A.4
Beglinger, C.5
-
31
-
-
0026760187
-
Enhancing effects of cyclodextrins on nasal absorption of insulin in rats
-
[31] T. Irie, K. Wakamatsu, H. Arima, H. Aritomi and K. Uekama, Enhancing effects of cyclodextrins on nasal absorption of insulin in rats, Int. J. Pharm. 84 (1992) 129-139.
-
(1992)
Int. J. Pharm.
, vol.84
, pp. 129-139
-
-
Irie, T.1
Wakamatsu, K.2
Arima, H.3
Aritomi, H.4
Uekama, K.5
|